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Abstract: Four polymer and ceramic computer-aided design/computer-aided manufacturing
(CAD/CAM) materials from different manufacturers (VITA CAD-Temp (polymethyl methacrylate,
PMMA), Celtra Duo (zirconia-reinforced lithium silicate ceramic, ZLS), IPS e.max CAD (lithium
disilicate (LS2)), and VITA YZ (yttrium-tetragonal zirconia polycrystal, Y-TZP)) were tested to evaluate
the cytotoxic effects and collagen type I secretions on human gingival fibroblasts (HGFs). A total of
160 disc-shaped samples (Ø: 10 ± 2 mm; h: 2 mm) were milled from commercial blanks and blocks.
Direct-contact cytotoxicity assays were evaluated at 24, 48, and 72 h, and collagen type I (COL1)
secretions were analysed by cell-based ELISA at 24 and 72 h. Both experiments revealed statistically
significant differences (p < 0.05). At 24 and 48 h of contact, cytotoxic potential was observed for all
materials. Later, at 72 h, all groups reached biologically acceptable levels. LS2 showed the best results
regarding cell viability and collagen secretion in all of the time evaluations, while Y-TZP and ZLS
revealed intermediate results, and PMMA exhibited the lowest values in both experiments. At 72 h,
all groups showed sharp decreases in COL1 secretion regarding the 24-h values. According to the
results obtained and the limitations of the present in vitro study, it may be concluded that the ceramic
materials revealed a better cell response than the polymers. Nevertheless, further studies are needed
to consolidate these findings and thus extrapolate the results into clinical practice.
Keywords: polymethyl methacrylate (PMMA); silicates/chemistry; CAD-CAM; materials testing;
biocompatible materials/chemistry; fibroblasts/cytology; cell survival; collagen type I
1. Introduction
Once implant osseointegration is achieved, a transepitelial abutment is placed for the soft tissue
remodelling process [1]. The abutment material should be as similar as possible to the natural tissues in
order to create a hermetic barrier [2] between the gingiva and abutment to achieve cellular proliferation
and protect the underlying implant These materials must be biocompatible [2–10] because dental
materials are always in contact with soft or bone tissue [6,11].
The study materials were milled using a computer-aided design/computer-aided manufacturing
(CAD/CAM) system. This technology was developed in 1985 [12] and has improved modern dentistry,
introducing new material designs. CAD/CAM offers a wide variety of advantages, such as reducing
production time and achieving mimetic and perfectly adapted structures [2,6,13–17].
Zirconia is one of the most used CAD/CAM materials, but it suffers from expansion during cooling
after sintering. This volumetric change is associated with the transformation from the tetragonal
to monoclinic phase and can promote the propagation of cracks in its structure. The addition of
a stabilizing agent, such as yttrium oxide (Y2O3), reinforces the zirconium oxide and prevents this
transformation phase and the propagation of cracks. Adding 3–6% of yttrium to zirconia leads to the
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formation of yttrium-tetragonal zirconia polycrystal (Y-TZP) and is the type of zirconia most commonly
used in dentistry [18–21].
Pre-sintered zirconia is usually employed to more easily handle the soft material and prevent the
transformation phase induced by the milling of CAD/CAM materials, which are more susceptible to
forming cracks on their structure [22]. Nevertheless, this material exhibits good mechanical properties,
largely due to the particle size of the structure (0.2–0.5 µm), which helps to maintain the stable
tetragonal phase. It presents a high flexural strength (900–1200 MPa), fracture resistance (7–10 MPa
m1/2), and elasticity modulus (210 GPa). It is increasingly considered to be the alternative to titanium
for aesthetic dental implant abutments in final restorations.
Other ceramic materials are also widely used in dentistry [23,24], such as lithium disilicate
(Li2Si2O5) glass ceramic. This material has been used for CAD/CAM manufacture since 2006
under the name IPS e.max CAD® and has diverse indications (e.g., crowns, inlays, onlays, implant
crowns, and veneers) because of its aesthetic properties and mechanical strength [2,6,17,23–26]. It is
commercialised as pre-crystallised blue blocks, which have a metasilicate and lithium disilicate nucleus.
This nucleus has good mechanical properties (flexural force of 130 MPa), which increase up to 360 MPa
during the crystallisation process (sintering at 850 ◦C for 20–25 min), according to the manufacturer.
Metasilicate is dissolved and leaves lithium disilicate crystals that can be coloured during the glazing
process [2,6,13,15,23–25,27–29]. The final mechanical properties are a fracture resistance of 2.25 MPa
m1/2, flexural strength of 360 MPa, and elastic modulus of 95 GPa [30].
A new material has emerged to satisfy the need for a material with the good mechanical properties
of zirconia and the good aesthetic properties of lithium disilicate (LS2) [31]. This material is made
by combining a vitreous matrix of lithium silicate and a crystal nucleus of zirconia, leading to the
formation of zirconia-reinforced lithium silicate ceramic (ZLS). It was developed in 2013 by two
manufacturers: Degudent and VITA Zahnfabrik at the Institute for Silicate Research in Germany.
One of the commercialised materials is Celtra® Duo and has a fast CAD/CAM manufacturing process
and better optical and mechanical properties than LS2 [32–34]. It has a high fracture resistance of
2 MPa m−1, elastic modulus of 70 GPa, and flexural strength of 200 MPa [35–37], and it is used for
single anterior and posterior crowns, inlays, onlays, and veneers [37].
Recently, CAD/CAM materials were developed for temporary restorations, one of which is
poly(methyl methacrylate) (PMMA), which is a synthetic polymer material that has been used in
dentistry since 1930 for orthodontics, removable prostheses, and splint manufacturing [38]. Its colour
stability, resistance, and ease of preparation make it an ideal provisional material [38–42]. Interim
restorations are an essential part of the process, especially in fixed implant prosthesis treatment [38,42],
preventing bacterial contamination and improving abutment health [38]. Vita CAD-Temp®
was introduced to the market in 2005 as chemically improved polymer CAD/CAM blanks [43].
This PMMA-based polymer material is pre-polymerised before market distribution blocks. This reduces
time and cost in the laboratory, eliminates polymerisation shrinkage [44], reduces clinical chairside,
and unpleasant smells because the material is not mixed manually or in a cartridge, and it improves
outcomes in terms of a better marginal fit and strength [12,38,42]. It is one of the most used temporary
materials before the placement of the final restoration [38,45,46] and is also used in surgical guide
manufacturing. It has good mechanical properties with a high elastic modulus (2800 MPa) and flexural
resistance (>80 MPa), which makes it a long-term provisional material [39,47].
The aim of this in vitro study was to compare the early response of human gingival fibroblasts of
four dental materials relative to biocompatibility and collagen secretion. To this end, we conducted an
MTT cytotoxicity test, which measures cellular viability through mitochondria metabolism, and an
enzyme-linked immunosorbent assay to measure collagen type I secretion.
To our knowledge, there are no other publications that compare these four materials in terms of
their biocompatibility and COL1 secretion assays. Three publications compare some of these materials
separately [13,17,48].
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The null hypothesis was that the all-ceramic (Vita YZ® T, ZLS Celtra® Duo and IPS e.max® CAD)
and interim materials (Vita CAD Temp®) do not significantly influence HGF viability and collagen
type I secretion.
2. Materials and Methods
2.1. Sample Preparation
Four CAD/CAM materials groups were used: Vita CAD-Temp® (VITA Zahnfabrik, Bad
Säckingen, Germany), IPS e.max® CAD (Ivoclar Vivadent, Schaan, Liechtenstein), VITA YZ® T
(Vita Zahnfabrik, Bad Säckingen, Germany), and Celtra® Duo (Degudent GmbH, Hanau-Wolfgang,
Germany); the manufacturers’ details are summarised in Table 1.
Table 1. The brand names, types, compositions, and manufacturers’ data of the materials.
Specimen Material Type Composition Manufacturer Lot No.
Vita CAD-Temp®
monoColor
(PMMA)
Polymethacrylate C5O2H8, SiO2 andpigments
VITA Zahnfabrik, Bad
Säckingen, Germany 1M27/51750
Celtra®
Duo (ZLS)
Zirconia-reinforced
lithium silicate
SiO2, Li2O, P2O5,
Al2O3, ZrO2, CeO2,
Tb2O3
Degudent GmbH,
Hanau-Wolfgang,
Germany
HT-A1-C14/16002830
IPS e.max® CAD
(LS2)
Vitreous ceramic
lithium disilicate
SiO2, Li2O, K2O,
MgO, ZnO, Al2O3,
P2O5
Ivoclar Vivadent, Schaan,
Liechtenstein
HT A1/C1 4
/V28352
VITA YZ®
(Y-TZP)
Zirconia partially
stabilised with
yttrium oxide
Al2O3, ZrO2, Y2O3,
Fe2O3, Er2O3,
Hf2O3
VITA Zahnfabrik, Bad
Säckingen, Germany YZ Twhite/74970
One hundred and sixty disc-shaped specimens (10 ± 2 mm in diameter and 2 mm in width) were
milled from commercial blanks and blocks, as can be seen in Figure 1.
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value of ± 25µm). The milling process was made with the following drills: Step Bur 12S and Cylinder
Pointed Bur 12S (PMMA blocks), Step Bur 12 and 12S, Cylinder Pointed Bur 12 and 12S (ZLS blocks),
Step Bur 12S, 12 and 20, Cylinder Pointed Bur 12S, 20 and 12EF (LS2 blocks), and Step Bur 20, Cylinder
Pointed Bur 20, Shaper 25 RZ and Finisher 10 (Y-TZP blanks, dry-milling).
Once the milling process was finished, lithium disilicate (LS2) was crystallised in Programat®
P700 (Ivoclar Vivadent, Schaan, Liechtenstein), a ceramic furnace that works in vacuum conditions at a
temperature range between 840 and 850 ◦C for 20–30 min. Furthermore, the zirconia (Y-TZP) sintering
process was performed in a VITA ZYRCOMAT 6000 MS furnace (VITA Zahnfabrik, Bad Säckingen,
Germany) with the YT Universal program at 1530 ◦C for 4 h and 40 min.
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Zirconia-reinforced lithium silicate (ZLS) blocks are commercialised in a fully sintered state with
the final restoration shade; it is unnecessary to carry out additional sintering, unless better mechanical
properties are demanded. This is a valid alternative to LS2 when high aesthetic quality and time savings
are required. PMMA is a polymer composite, so there is no need for a sintering or crystallisation
process, as indicated by the manufacturer.
When the milling only (PMMA and ZLS) and the milling and sintering (Y-TZP and LS2) processes
were finished, we obtained discs of 10 ± 2 mm diameter and 2 mm height (final dimensions of all discs).
Discs were then cleaned by immersion with absolute ethanol and sterilised with short-wavelength
(200–280 nm) UV-C exposure for 30 min on each side inside a laminar flow workstation. Next, discs were
placed on sterile 48-well plates and were used as cell seeding substrates for both experiments (Figure 2).
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2.2. Cell Culture
Human gingival fibroblasts (Innoprot, Bizkaia, Spain) were cultured in tissue flasks of polystyrene
in a CO2 incubator in a Nuaire US Autoflow NU-4750-E (Nuaire, Plymouth, Minnesota, USA) at 37 ◦C
in humidified 5% carbon dioxide (CO2) with a 95% air atmosphere for 1–2 weeks. Dulbecco’s
modified Eagle medium (DMEM, Biowest, Nuaillé, France) was supplemented with 10% FBS
(Biowest, Nuaillé, France) and 1% glutamine–penicillin–streptomycin (Biowest, Nuaillé, France).
The medium was changed every 48 h, and the cells were subcultured regularly upon reaching 80%
confluence. Later, the cells were passaged after trypsinization using 0.25% trypsin (Biowest, Nuaillé,
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France) and Dulbecco’s phosphate-buffered saline without calcium and magnesium (DPBS, Lonza,
Basel, Switzerland), which was previously tempered in a water bath at 37 ◦C. Cellular growth, adhesion,
and proliferation were monitored with an Olympus CKX41SF2 microscope (Olympus, Shinjuku-ku,
Tokyo, Japan). Cultured HGFs from the second to eighth passages were used for the experiments.
2.3. Cytotoxicity Assay
With the purpose of evaluating the cytotoxicity of the materials, a cell viability assay was carried
out at 24, 48, and 72 h. The protocol used is based on measurements of the viability of cells through
metabolic activity in a colorimetric test.
MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromid) is a yellow-coloured
tetrazolium water-soluble salt that is metabolically reduced by mitochondrial succinate dehydrogenase
(SDH) from viable cells, produces formazan products (blue-violet salt), cannot cross plasmatic
membranes, and accumulates in the cells [13,48–51]. The number of viable cells is correlated with
the colour intensity determined by photometric measurements when formazan is dissolved in
alcohol. The MTT cell proliferation assay (ab211091 kit, Abcam, Cambridge, UK) was performed by a
direct-contact method according to ISO 10993-5:2009. This standard establishes that a material has a
cytotoxic potential if cell viability is reduced below 70% [52].
Reaching 80% confluence, the cells were removed from culture flasks by enzymatic digestion
Trypsin/EDTA 0.25% and centrifuged using Allegra™ X-22R Centrifuge (Bekman Coulter, Indianapolis,
Indiana, USA) at 200 g for 3 min. A total of 96 discs was used for this experiment. Four discs were used
for each material and evaluation time (24, 48, and 72 h) and were placed in 48-well plates. The same
number of wells were used for the controls and blanks. Fibroblasts were seeded at a concentration of
1 × 105 cells/disc in 500 µL of MEM (Sigma-Aldrich, St. Luis, MO, USA). The same cell concentration
was cultured on empty 48-well plates as a control group. Wells containing only MEM were used as
blanks. MEM was used without FBS or phenol red to avoid the overlapping of serum proteins and
MTT absorbance.
At determined evaluation times, the medium was removed and replaced by MEM and MTT
reagent during 3 h of incubation. Next, the formation of formazan crystals was checked under an
inverted microscope and a dissolvent reagent was added. Plates were shaken for 15 min, and 250 µl
of each well was placed in a 96-microwell plate. The optical density (OD) of the resulting solution
was measured with a Synergy HT microplate reader (Biotek, Winooski, VT, USA) and Gen5™ Data
Analysis Software (Winooski, VT, USA) at 590 nm. The mean absorbance values (samples and controls)
were corrected for the mean absorbance of the blanks.
Cell viability was calculated as a percentage in relation to the control group, taken as 100% with
the following formula: % viability = [(Sample absorbance – Blank absorbance) / (Control absorbance –
Blank absorbance)] × 100.
2.4. Type I Collagen Secretion (ELISA)
To determinate the secretion of collagen type I into the medium by HGFs seeded on the discs,
a double-antibody sandwich ELISA assay (ELISA Kit MyBioSource, San Diego, CA, USA) was
performed. After 24 h and 72 h of incubation, the supernatant was collected, centrifuged, and analysed
by an enzyme-linked immunosorbent assay. A total of 64 discs were used, with four discs per material
and time evaluation. The cells were seeded at a density of 3 × 105 cells/disc in 500 µl of MEM. MEM was
used for the same reasons as those stated above. Discs were placed in 48-well plates for the experiment.
Briefly, dilutions were prepared in a dilution buffer. On an antibody-precoated 96-microwell plate,
100 µl of dilutions and 100 µl supernatants were added to each well. Collagen was detected by the
human COL1 monoclonal antibody. Next, the biotin labelling antibody was added and washed with a
washing buffer. Later, avidin–horseradish peroxidase conjugates were added to the wells; the plate
was washed to remove the unbound enzyme-labelled antibodies. A TMB substrate was used to colour
the peroxidase catalyst blue, which turns yellow upon reaction to sulfuric acid. The plates were
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read at 450 nm with a Synergy HT microplate reader and Gen5™ Data Analysis Software. The mean
absorbance values (samples and controls) were corrected for the mean absorbance of the blanks. A
standard curve was assessed to interpolate optical density (OD) values to the concentrations of collagen
type I (ng/mL).
2.5. Statistical Analysis
The comparison of the groups for each of the analysed variables was made using IBM SPSS Statistics
24.0 software (International Business Machines Corp., New York, NY, USA). The Kolmogorov–Smirnov
test was performed to verify normal distribution. The homogeneity equality of variance was checked
using Levene’s test. One-way analysis of variance (ANOVA) was calculated to assess the statistical
significance of differences in cell viability and collagen type I secretion. Post hoc comparisons were
undertaken with Bonferroni and Games–Howell tests for equal or unequal variances, respectively.
The level of significance was set at p < 0.05. Results were reported as a mean ± standard deviation (SD).
3. Results
3.1. Cytotoxicity of CAD/CAM Materials
In order to evaluate the cytotoxicity of the materials, cell viability was measured by a direct-contact
MTT assay at three evaluation times (24 h, 48 h, and 72 h). The results revealed a significant and linear
effect of time (p < 0.01) and type of material (p < 0.05) on the cell viability. Cytotoxicity decreased over
time (Figure 3). Significant differences among groups were shown at 24 h (p < 0.01). LS2 revealed the
highest viability (59.46% ± 3.32%) and PMMA the lowest (40.65% ± 3.32%); both were compared to the
other materials (Y-TZP (54.74% ± 3.90%) and ZLS (42.20% ± 2.74%)). There were significant differences
between all groups (p < 0.02), except between ZLS and PMMA (p > 0.05).Polymers 2019, 11, x FOR PEER REVIEW 7 of 16 
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(67.35% ± 7.20%), and PMMA showed the lowest (58.85% ± 3.18%), compared with the LS2, Y-TZP
(62.04% ± 3.26%) and ZLS (60.51% ± 2.69%) groups, but there were only significant differences when
comparing LS2 with ZLS (p = 0.02) and LS2 with PMMA (p < 0.01).
At 72 h, all materials showed the highest viability between the three points of time evaluation.
The group with the highest cell viability was LS2 (94.52% ± 2.30%), and PMMA showed the lowest
(86.62% ± 3.75%). The statistically significant differences seen at 48 h remained at 72 h between LS2
and ZLS (p = 0.01) and LS2 with PMMA (p < 0.01). There was also a significant difference between
Y-TZP and PMMA (p < 0.01).
3.2. Evaluation of Collagen Type I Secretion (ELISA)
After seeding HGFs for 24 and 72 h, the secretion of collagen type I to the culture medium
was quantified through an ELISA assay. A standard curve was defined by the absorbance from the
standards containing known concentrations of COL1 (Figure 4).
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Figure 4. Standard curve used in ELISA assay. In the top-left box, the equation of the line used
to obtain the concentrations of the samples is given, in addition to the correlation coefficient R2,
which indicates a strong relation between the two variables (optical density (OD) and collagen type I
(COL1) concentration) as it is close to 1.
After 24 h of cultivation, levels of collagen type I showed differences between groups (p < 0.01)
(Figure 5). LS2 (5.56± 0.41 ng/mL) showed the highest secretions (p < 0.01) compared to the other groups;
in decreasing order: Y-TZP (3.89± 0.14 ng/mL), ZLS (3.77± 0.30 ng/mL), and PMMA (3.01 ± 0.06 ng/mL).
The collagen secretion measured in the polystyrene control surface (1.63 ± 0.22 ng/mL) was significantly
lower than the other groups (p < 0.01). There were statistically significant differences between all
groups, except between ZLS–Y-TZP (p > 0.05) and ZLS–PMMA (p = 0.05).
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materials according to the in vitro‐type assay. Publications that do not apply an ISO standard add 
other variables that complicate the comparison between in vitro studies and the interpreted results 
[57]. Therefore, conclusions derived from comparisons made with no standardised viability assays 
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Most of the studies use an MTT assay, but this is not the only way to analyse cellular viability. 
One of the methods used was the (2,3‐bis(2‐methoxy‐4‐nitro‐5‐sulfophenyl)‐5‐
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another salt that produces formazan through mitochondrial dehydrogenases [17,52]. Other similar 
colorimetric assays are the MTS test and XPS test [6]. 
Figure 5. Type I secretion levels at 24 and 72 h.
At 72 h, the levels of secretion of collagen were sharply reduced in all groups (p < 0.01
for all groups). The same trend of group distribution was observed. LS2 showed the lowest
reduction (2.24 ± 0.13 ng/mL), followed by Y-TZP (1.50 ± 0.08 ng/mL), ZLS (0.6 ± 0.08 ng/mL), PMMA
(0.38 ± 0.15 ng/mL), and the control group (0.21 ± 0.03 ng/mL). The latter group revealed the highest
decrease in collagen secretion. There were significant differences between groups (p < 0.01), except for
PMMA–ZLS and PMMA–control (p > 0.05 for both comparisons).
4. Discussion
Biocompatibility refers to a material’s ability to not affect the local or systemic behaviour of an
organism. Cytotoxicity is an important biocompatibility component [11,53]. It can be studied in in vivo
or in vitro studies. The former has some disadvantages, such as being difficult to control and interpret,
in addition to legal and ethical considerations. Nevertheless, the latter offers important advantages:
the possibility to study a reaction cell of interest, lower variability results, and easier access to the
investigated site [11,51,53,54]. Most in vitro studies of dental material cytotoxicity are cell culture
systems [53].
This study investigates the human gingival fibroblasts’ response to the MTT cytotoxicity method
and collagen type I secretion on dental CAD/CAM materials, which are widely used as implant crowns
and implant transmucosal abutments. Unlike immortal cell lines, primary HGFs keep phenotypically
similar features to normal cells, resulting in a very similar imitation to in vivo circumstances [6,49].
Gingiva is the epithelium in charge of creating a barrier (biological seal) between the abutment
and the connective tissue. This barrier should adhere to the implant abutment surface, which has the
function of creating stability between soft and hard tissues (protecting implant—abutment connection
and peri-implant bone), protection against noxious bacteria, and has an acceptable aesthetic quality.
The protective barrier requires a nontoxic material that favours the attachment and growth of the
surrounding tissues [5,49,54–56].
A cell viability assay was conducted with a colorimetric MTT study based on the mitochondrial
activity of cells in direct contact with the different surfaces. This kind of research is undertaken in
accordance with ISO 10993-5, resulting in a standardised methodology and an objective numeric
comparison of the obtained results. Nevertheless, the ISO standard does not have a defined
classification to establish cell viability value ranges to determine the grade of cytotoxicity of the
materials according to the in vitro-type assay. Publications that do not apply an ISO standard add
other variables that complicate the comparison between in vitro studies and the interpreted results [57].
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Therefore, conclusions derived from comparisons made with no standardised viability assays should
be interpreted with caution.
Most of the studies use an MTT assay, but this is not the only way to analyse cellular viability. One of
the methods used was the (2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino)carbonyl]-2H-
tetrazolium hydroxide) (XTT) cytotoxicity test, which used XTT, another salt that produces formazan
through mitochondrial dehydrogenases [17,52]. Other similar colorimetric assays are the MTS test and
XPS test [6].
MTT is not a new cellular proliferation assay in dentistry. In the year 1993, Li et al. published an
experiment about cell reactions to zirconia and other ceramics. Another classic study investigated
the cytotoxicity of some metals and ceramics in relation to mouse fibroblasts. They concluded that
all ceramic materials had an appropriate biocompatibility [58]. Recently, the biocompatibility of
all-ceramic CAD/CAM materials has also been studied [2,25,58–60], and the present study contributes
to this research.
Our results demonstrated good biocompatibility levels in all the analysed materials. We studied
viability levels using a direct-contact MTT assay evaluated at 24, 48, and 72 h periods on three all-ceramic
CAD/CAM materials and one polymer-based CAD/CAM material. We determined ascendant viability
values over the time points (viability at 72 h > 48 h > 24 h). LS2 viability stood out significantly over all
the other materials throughout the three-time evaluation points (p < 0.05); however, although some of
the differences were statistically significant, Y-TZP and ZLS showed similar viability at 48 and 72 h.
The distribution of values was similar in the three studied time lapses. PMMA showed the lowest
viability during the three times evaluation points, which also increased over time.
Recently, Atay et al. sought to define a classification where a cell viability above 90% infers the
material is not cytotoxic, values between 60–90% are considered slightly cytotoxic, values of 30–59%
are moderately cytotoxic, and those below 30% are considered severely cytotoxic [17]. According
to this classification, all materials should be considered as moderately cytotoxic at 24 h, all would
be considered slightly cytotoxic at 48 h (except PMMA, which would remain moderately cytotoxic),
and ZLS and PMMA should be considered as slightly cytotoxic at 72 h. After three days, LS2 and Y-TZP
should be considered as not cytotoxic. In Atay et al., the cytotoxic evaluation of different CAD/CAM
materials was performed using extracts from the culture medium and not by direct contact, so this
should be considered.
Lithium disilicate and zirconia are two widely used materials in dentistry because of their good
optical and mechanical properties. However, LS2 cytotoxicity remains unclear according to the
conditions of the study. Some publications have reported the cytotoxicity of this material [24,61],
and there is no clear consensus when comparing lithium disilicate and zirconia. A key factor could be
the type of cells seeded on the surfaces. In some studies, LS2 has been considered cytotoxic for HGFs,
categorizing it as a second-class biomaterial [2,6,13,23,28]. In another study, it was observed—despite
both materials being biocompatible—that proliferation and viability rates were higher in LS2 for
epithelial cells [62].
There are many studies comparing zirconia with titanium [49,50,63,64], but only a few have
compared CAD/CAM-ceramics with CAD/CAM-polymers. Raffaeli et al. compared the response of rat
immortalised fibroblasts to zirconia and feldspathic ceramics, and their findings suggested a better
viability in zirconia. In that study, as in ours, they used polystyrene as a control. This material promotes
growth and cell adhesion, which makes it widely used for in vitro assays [51]. Similar viability results
were obtained in other studies when comparing CAD/CAM zirconia and LS2 with feldspathic veneer
ceramic, revealing a higher viability for the first two ceramic materials [13].
ZLS is a new material, and there are many publications about the product’s mechanical properties
but few about its biocompatibility. In 2017, Dal Pilva et al. conducted a similar study comparing ZLS
and Y-TZP cytotoxicity at 24 h. They also reported severe cytotoxicity (<50% cell viability) at early
contact [48].
Polymers 2019, 11, 1446 10 of 15
We could only find one study that evaluated CAD/CAM all-ceramic materials and interim
prosthesis materials in a proliferation assay. This study revealed a high cell viability (above 90%) for
all materials at 24 and 72 h and on the seventh day. Nevertheless, the authors considered zirconia,
LS2, and Vita CAD-Temp materials as slightly cytotoxic at all incubation periods. This disparity
between those results and ours could be explained by the fact that, in the mentioned study, the XTT
viability assay was undertaken by an extract method, which could be a potential differentiating factor
to consider [17].
One reason for this acute cytotoxicity in the first 24 h has been described by other authors: in
the very first hours of the material immersion in the medium culture, ion leaching from ceramics can
be expected. This phenomenon is responsible for cytotoxicity to a greater or lesser degree. In our
experiment, the two main inorganic elements that are potentially released by LS2 and ZLS are alumina
and silicon, both of which are considered to have low cytotoxicity [65,66]. Some studies also blame
this low viability on Zn, an LS2 component considered by some as a cellular-viability suppressor or
cytotoxicity increaser [24]. In the case of monolithic zirconia, the leaching elements could be zirconia,
yttrium, silicon, and sodium. Nevertheless, polycrystalline ceramic is free from serious corrosion, and
the cytotoxic potential of these elements is moderately low, according to the literature reviewed [66–69].
The most used dental interim materials are made with polymethyl methacrylate, polyethylene
methacrylate, or bis-acryl resins. The polymerisation process of these materials produces by-products
and unreacted monomers (polymerisation shrinkage) that can be noxious to gingival tissues. When these
materials are commercialised in CAD/CAM blocks, they are pre-polymerised, reducing the harmful
effects [17,39,45]. However, an incomplete pre-polymerisation may cause the leaching of some of
the components of these resin materials [17,70]. The oral environment can lead to the materials’
biodegradation, leaching potentially toxic agents (monomers, in most cases) that affect cells and
tissues [39,71]. Degradation takes place as a result of multiple factors (e.g., saliva, bacteria colony,
and mastication) [71]. Saliva is fundamentally composed of water, whose molecules can enter the
polymers’ structure and give rise to monomer and additive diffusion [17,70,71]. This phenomenon can
occur in in vitro conditions as well, due to the aqueous base of the culture medium that can generate
similar consequences as those of saliva [71].
Shim et al. compared some provisional materials in relation to the cytotoxic effect of HGFs,
and they concluded PMMA and bis-acryl (viability >80%) have much better effects with fibroblasts than
poly(ethyl methacrylate). However, Atay et al. considered Vita CAD-Temp to be slightly cytotoxic.
Our PMMA results can be explained if we consider that this is not a definitive material.
This polymer can be used as a long-term provisional material, lasting up to two years according to
the manufacturer. We cannot expect this polymer to exhibit definitive material behaviour because
this kind of product is commercialised with the purpose of conforming the gingival tissue before the
definitive material is placed, and also to protect the peri-implant space [38,42]. However, it should be
easily removed by a professional without producing a new soft-tissue regenerating period.
In accordance with the obtained results, it cannot be said that these materials are totally inert;
nevertheless, the cytotoxic values after 72 h are within the biocompatibility range for clinical use,
as other authors have claimed [17,72,73].
After the placement of an implant abutment during the second-stage surgery, the wound must
heal through the migration of fibroblasts and the formation of a collagen matrix [55]. To achieve
the successful integration of a ceramic material, cells must colonise the surface, and elements of the
extracellular matrix (ECM) must be remodelled, such as collagen, which plays an important role in cell
adhesion to a surface [13,74].
Many of the published studies measure collagen mRNA expression, along with other cellular
adhesion proteins, through reverse transcription polymerase chain reaction (PCR) assays. In these
cases, collagen type I mRNA is isolated and extracted from HGFs, cultured on different study materials,
and converted to cDNA [50,56,63]. Nevertheless, few publications have evaluated the collagen secretion
on ceramic material through enzyme-linked immunoabsorption assays.
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Fibroblasts are continually remodelling their ECM conformation because they adhere to a surface.
These adjustments are done through the synthesis and proteolysis of the components. In our study,
collagen type I secretion to the culture medium was determined in order to evaluate the correct
function of fibroblasts. After 24 h, LS2 was the surface with the highest level of collagen secretion,
with statistically significant differences observed between all groups (p < 0.01), except in ZLS, Y-TZP,
and PMMA, which showed similar values (p > 0.05). Collagen secretion decreased sharply for
all groups at 72 h, and again, LS2 was the surface with the highest value (p < 0.01). At this time
evaluation point, there were no significant differences in ZLS, PMMA, and the polystyrene control
group. The reason for this drastic secretion decrease has been explained by other publications [13,63].
Tetè et al. compared collagen type I secretion by HGFs at 24 and 72 h on different polished
and unpolished ceramic surfaces and a polystyrene control. At 24 h, no significant differences were
observed for polished or unpolished zirconia and glazed feldspathic surfaces; however, secretion
levels on a polished LS2 surface were statistically lower. At 72 h, a sharp decrease was detected in all
groups and was statistically significant for both polished zirconia and LS2 surfaces [13]. The control
surface revealed the lowest secretion levels at both time evaluation points. Some researchers have
attributed this to the maximum proliferation levels on polystyrene surfaces at the expense of the
synthesis and assembling of the ECM components [75]. They stated that, in normal in vivo conditions,
cells show a minimum proliferation rate and high collagen secretion levels, but in in vitro conditions,
cellular behaviour is different. In the first hours of in vitro testing, cells showed a greater tendency
to secrete collagen to enhance adhesion to the substrate and later on stimulating their proliferation.
This could explain why collagen secretion sharply decreases beyond 72 h after cells adhere [13].
When cellular confluence is reached, proliferation stops by inhibition contact, and collagen secretion
also decreases drastically after cells anchor to the surface [63].
The low values obtained in our results are due to another cause: collagen secretion differs
depending on the type of fibroblast. Gingival fibroblasts express less collagen and present a different
ECM organisation regarding periodontal ligament fibroblasts because HGFs have a lower expression
of α2β1 and α10β1 integrins [76–79].
More research is needed to analyse the possible relationship between surface, material type,
cell proliferation, and ECM protein secretions, such as collagen. In in vitro studies, factors such as
the percentage of supplemented FBS, pH, or the composition of the culture medium are additional
variables that can influence the collagen levels secreted by cells [79]. Assays should be undertaken
under ISO standards in order to be reproducible and make objective comparisons of the results [6,9,80].
5. Conclusions
According to the results obtained and the limitations of the present in vitro study, it may be
concluded that ceramic materials—more precisely, lithium disilicate—revealed better cell responses
than polymers in terms of cell viability and collagen type I secretion. Regarding direct-contact
cytotoxicity, a linear effect of time and type of material was observed with decreased cytotoxicity
over time (p < 0.05). At 72 h, all groups reached biologically acceptable levels. Lithium disilicate
showed the highest levels of collagen type I both at 24 and 72 h. The secretion levels were sharply
reduced in all groups at 72 h (p < 0.01). Polymers showed poor results on both types of experiments.
Nevertheless, further studies are needed to consolidate these findings and thus extrapolate the results
into clinical practice.
Author Contributions: Conceptualization, M.R.-G., C.H.-G., D.T.-L. and J.-L.G.-P.; formal analysis, M.R.-G.
and C.H.-G.; investigation, M.R.-G. and C.H.-G.; methodology, M.-A.S.-F.; project administration, J.-L.G.-P.;
supervision, D.T.-L., M.-A.S.-F. and J.-L.G.-P.; Validation, D.T.-L.; writing—original draft, M.R.-G., C.H.-G. and
M.-A.S.-F.; writing—review & editing, M.R.-G., C.H.-G., D.T.-L., M.-A.S.-F. and J.-L.G.-P..
Funding: This research received no external funding.
Polymers 2019, 11, 1446 12 of 15
Acknowledgments: The authors gratefully thank the Biology and Microscopy Departments from the
Centre of Investigation, Technology and Innovation from Seville University (CITIUS) for their support and
experimental assistance.
Conflicts of Interest: The authors declare no conflict of interest.
References
1. Grenade, C.; De Pauw-Gillet, M.-C.; Pirard, C.; Bertrand, V.; Charlier, C.; Vanheusden, A.; Mainjot, A.
Biocompatibility of polymer-infiltrated-ceramic-network (PICN) materials with Human Gingival
Keratinocytes (HGKs). Dent. Mater. 2017, 33, 333–343. [CrossRef] [PubMed]
2. Pabst, A.M.; Walter, C.; Grassmann, L.; Weyhrauch, M.; Brüllmann, D.D.; Ziebart, T.; Scheller, H.; Lehmann, K.M.
Influence of CAD/CAM all-ceramic materials on cell viability, migration ability and adenylate kinase release of
human gingival fibroblasts and oral keratinocytes. Clin. Oral Investig. 2014, 18, 1111–1118. [CrossRef] [PubMed]
3. Herráez-Galindo, C.; Rizo-Gorrita, M.; Luna-Oliva, I.; Serrera-Figallo, M.Á.; Castillo-Oyagüe, R.;
Torres-Lagares, D. In vitro Comparative Study of Fibroblastic Behaviour o Polymethacrylate (PMMA)
and Lithium Disilicate Polymer Surfaces. Polymers 2019, 11, 744. [CrossRef]
4. Rizo-Gorrita, M.; Luna-Oliva, I.; Serrera-Figallo, M.Á.; Gutiérrez-Pérez, J.L.; Torres-Lagares, D. Comparison
of Cytomorphometry and Early Cell Response of Human Gingival Fibroblast (HGFs) between Zirconium
and New Zirconia-Reinforced Lithium Silicate Ceramics (ZLS). Int. J. Mol. Sci. 2018, 19, 2718. [CrossRef]
5. Mehl, C.; Kern, M.; Schütte, A.M.; Kadem, L.F.; Selhuber-Unkel, C. Adhesion of living cells to abutment materials,
dentin, and adhesive luting cement with different surface qualities. Dent. Mater. 2016, 32, 1524–1535. [CrossRef]
[PubMed]
6. Grenade, C.; de Pauw-Gillet, M.C.; Gailly, P.; Vanheusden, A.; Mainjot, A. Biocompatibility of
polymerinfiltrated- ceramic-network (PICN) materials with Human Gingival Fibroblasts (HGFs). Dent. Mater.
2016, 32, 1152–1164. [CrossRef]
7. Nothdurft, F.P.; Fontana, D.; Ruppenthal, S.; May, A.; Aktas, C.; Mehraein, Y.; Lipp, P.; Kaestner, L. Differential
Behavior of Fibroblasts and Epithelial Cells on Structured Implant Abutment Materials: A Comparison of
Materials and Surface Topographies. Clin. Implant Dent. Relat. Res. 2015, 17, 1237–1249. [CrossRef]
8. D’Addona, A.; Ghassemian, M.; Raffaelli, L.; Manicone, P.F. Soft and hard tissue management in implant
therapy-part I: Surgical concepts. Int. J. Biomater. 2012, 2012, 531202. [CrossRef]
9. Fischer, N.G.; Wong, J.; Baruth, A.; Cerutis, D.R. Effect of Clinically Relevant CAD/CAM Zirconia Polishing
on Gingival Fibroblast Proliferation and Focal Adhesions. Materials 2017, 10, 1358. [CrossRef]
10. Miyazaki, T.; Nakamura, T.; Matsumura, H.; Ban, S.; Kobayashi, T. Current status of zirconia restoration.
J. Prosthodont. Res. 2013, 57, 236–261. [CrossRef]
11. Elshahawy, W.; Shohieb, F.; Yehia, H.; Etman, W.; Watanabe, I.; Kramer, P. Cytotoxic effect of elements
released clinically from gold and CAD-CAM fabricated ceramic crowns. Tanta Dent. J. 2014, 11, 189–193.
12. Srinivasan, M.; Gjengedal, H.; Cattani-Lorente, M.; Moussa, M.; Durual, S.; Schimmel, M.; Müller, F.
CAD/CAM milled complete removable dental prostheses: An in vitro evaluation of biocompatibility,
mechanical properties, and surface roughness. Dent. Mater. J. 2018. [CrossRef]
13. Tetè, S.; Zizzari, V.L.; Borelli, B.; De Colli, M.; Zara, S.; Sorrentino, R.; Scarano, A.; Gherlone, E.; Cataldi, A.;
Zarone, F. Proliferation and adhesion capability of human gingival fibroblasts onto zirconia, lithium disilicate
and feldspathic veneering ceramic in vitro. Dent. Mater. J. 2014, 33, 7–15. [PubMed]
14. Awada, A.; Nathanson, D. Mechanical properties of resin-ceramic CAD/CAM restorative materials. J. Prosthet.
Dent. 2015, 114, 587–593. [CrossRef] [PubMed]
15. Zarone, F.; Ferrari, M.; Mangano, F.G.; Leone, R.; Sorrentino, R. “Digitally Oriented Materials”: Focus on
Lithium Disilicate Ceramics. Int. J. Dent. 2016, 2016, 9840594. [CrossRef] [PubMed]
16. Horvath, S.D. Key Parameters of Hybrid Materials for CAD/CAM-Based Restorative Dentistry.
Compend. Contin. Educ. Dent. 2016, 37, 638–643. [PubMed]
17. Atay, A.; Gürdal, I.; Çetıntas, V.B.; Üs¸ümez, A.; Cal, E. Effects of New Generation All-Ceramic and Provisional
Materials on Fibroblast Cells. J. Prosthodont. 2018, 28, e383–e394. [PubMed]
18. Chevalier, J. Critical effect of cubic phase on aging in 3mol% yttria-stabilized zirconia ceramics for hip
replacement prosthesis. Biomaterials 2004, 25, 5539–5545. [CrossRef] [PubMed]
Polymers 2019, 11, 1446 13 of 15
19. Chevalier, J.; Gremillard, L.; Virkar, A.; Clarke, D.R. The Tetragonal-Monoclinic Transformation in Zirconia:
Lessons Learned and Future Trends. J. Am. Ceram. Soc. 2009, 92, 1901–1920.
20. Kelly, J.R.; Denry, I. Stabilized zirconia as a structural ceramic: An overview. Dent. Mater. 2008, 24, 289–298.
[CrossRef]
21. Gupta, T.K.; Bechtold, J.H.; Kuznicki, R.C.; Cadoff, L.H.; Rossing, B.R. Stabilization of tetragonal phase in
polycrystalline zirconia. J. Mater. Sci. 1977, 12, 2421.
22. El-Ghany, O.S.A.; Sherief, A.H. Zirconia based ceramics, some clinical and biological aspects: Review.
Futur. Dent. J. 2016, 2, 55–64.
23. Willard, A.; Chu, T.M.G. The science and application of IPS e. Max dental ceramic. Kaohsiung J. Med. Sci.
2018, 34, 238–242. [CrossRef] [PubMed]
24. Brackett, M.G.; Lockwood, P.E.; Messer, R.L.; Lewis, J.B.; Bouillaguet, S.; Wataha, J.C. In vitro cytotoxic
response to lithium disilicate dental ceramics. Dent. Mater. 2008, 24, 450–456. [CrossRef] [PubMed]
25. Li, R.W.K.; Chow, T.W.; Matinlinna, J.P. Ceramic dental biomaterials and CAD/CAM technology: State of the
art. J. Prosthodont. Res. 2014, 58, 208–216. [CrossRef] [PubMed]
26. Simba, B.G.; Ribeiro, M.V.; Suzuki, P.A.; Alves, M.F.R.P.; Strecker, K.; Santos, C.D. Mechanical properties of
lithium metasilicate after short-term thermal treatments. J. Mech. Behav. Biomed. Mater. 2019, 98, 179–186.
[CrossRef] [PubMed]
27. Ortiz, A.L.; Borrero-López, O.; Guiberteau, F.; Zhang, Y. Microstructural development during heat treatment
of a commercially available dental-grade lithium disilicate glass-ceramic. Dent. Mater. 2019, 35, 697–708.
[CrossRef]
28. Kilic, K.; Kesim, B.; Sumer, Z.; Polat, Z.; Kesim, S. In vitro cytotoxicity of all-ceramic substructural materials
after aging. J. Dent. Sci. 2013, 8, 231–238.
29. Barone, S.; Freulon, A.; Malard, B.; Dehmas, M. Solid-state phase transformation in a lithium disilicate-based
glass-ceramic. J. Non-Crystalline Solids 2019, 513, 9–14.
30. IPS e.max ® CAD Scientific Documentation; Ivoclar Vivadent AG: Liechtenstein, France, 2017.
31. Silva, L.H.D.; Lima, E.; Miranda, R.B.P.; Favero, S.S.; Lohbauer, U.; Cesar, P.F. Dental ceramics: A review of
new materials and processing methods. Braz. Oral Res. 2017, 31, 58. [CrossRef]
32. Rinke, S.; Pabel, A.-K.; Rödiger, M.; Ziebolz, D. Chairside Fabrication of an All-Ceramic Partial Crown Using
a Zirconia-Reinforced Lithium Silicate Ceramic. Case Rep. Dent. 2016, 2016, 1354186. [CrossRef]
33. Sieper, K.; Wille, S.; Kern, M. Fracture strength of lithium disilicate crowns compared to polymer-infiltrated
ceramic-network and zirconia reinforced lithium silicate crowns. J. Mech. Behav. Biomed. Mater. 2017, 74, 342–348.
[CrossRef] [PubMed]
34. Lambert, H.; Durand, J.-C.; Jacquot, B.; Fages, M. Dental biomaterials for chairside CAD/CAM: State of the
art. J. Adv. Prosthodont. 2017, 9, 486–495. [CrossRef]
35. Elsaka, S.E.; Elnaghy, A.M. Mechanical properties of zirconia reinforced lithium silicate glass-ceramic. Dent.
Mater. 2016, 32, 908–914. [CrossRef] [PubMed]
36. Sen, N.; Us, Y.O. Mechanical and optical properties of monolithic CAD-CAM restorative materials. J. Prosthet.
Dent. 2018, 119, 593–599. [CrossRef] [PubMed]
37. Celtra® Duo Zirconia-Reinforced Lithium Silicate (ZLS) Block; Technical Monograph; Dentsply Sirona:
Hanau-Wolfgang, Germany, 2016.
38. Abdullah, A.O.; Pollington, S.; Liu, Y. Comparison between direct chairside and digitally fabricated temporary
crowns. Dent. Mater. J. 2018, 37, 957–963. [CrossRef]
39. Yao, J.; Li, J.; Wang, Y.; Huang, H. Comparison of the flexural strength and marginal accuracy of traditional
and CAD/CAM interim materials before and after thermal cycling. J. Prosthet. Dent. 2014, 112, 649–657.
[CrossRef] [PubMed]
40. Akin, H.; Tugut, F.; Polat, Z.A. In vitro comparison of the cytotoxicity and water sorption of two different
denture base systems. J. Prosthodont. 2015, 24, 152–155. [CrossRef] [PubMed]
41. Salido, M.; Vilches, J.I.; Gutiérrez, J.L. Actin cytoskeletal organization in human osteoblasts grown on
different dental titanium implant surfaces. Histol. Histopathol. 2007, 22, 1355–1364. [CrossRef]
42. Alp, G.; Murat, S.; Yilmaz, B. Comparison of Flexural Strength of Different CAD/CAM PMMA-Based
Polymers. J. Prosthodont. 2019, 28, e491–e495. [CrossRef]
Polymers 2019, 11, 1446 14 of 15
43. Huettig, F.; Prutscher, A.; Goldammer, C.; Kreutzer, C.A.; Weber, H. First clinical experiences with
CAD/CAM-fabricated PMMA-based fixed dental prostheses as long-term temporaries. Clin. Oral Investig.
2016, 20, 161–168. [CrossRef]
44. Lo Giudice, G.; Cicciù, M.; Cervino, G.; Lizio, A.; Visco, A.M. Flowable resin andmarginal gap on tooth third
medial cavity involving enamel and radicularcementum: A SEM evaluation of two restoration techniques.
Indian J. Dent. Res. 2012, 23, 763–769. [CrossRef]
45. Shim, J.S.; Kim, H.C.; Park, S.I.; Yun, H.J.; Ryu, J.J. Comparison of Various Implant Provisional Resin
Materials for Cytotoxicity and Attachment to Human Gingival Fibroblasts. Int. J. Oral Maxillofac. Implants
2019, 34, 390–396. [CrossRef] [PubMed]
46. Joda, T.; Ferrari, M.; Braegger, U. A digital approach for one-step formation of the supra-implant emergence
profile with an individualized CAD/CAM healing abutment. J. Prosthodont. Res. 2016, 60, 220–223. [CrossRef]
47. Özçelik, T.B.; Yilmaz, B.; ¸Seker, E.; Shah, K. Marginal Adaptation of Provisional CAD/CAM Restorations
Fabricated Using Various Simulated Digital Cement Space Settings. Int. J. Oral Maxillofac. Implants
2018, 33, 1064–1069. [CrossRef] [PubMed]
48. Dal Piva, A.; Contreras, L.; Ribeiro, F.C.; Anami, L.C.; Camargo, S.; Jorge, A.; Bottino, M.A. Monolithic
Ceramics: Effect of Finishing Techniques on Surface Properties, Bacterial Adhesion and Cell Viability.
Oper. Dent. 2018, 43, 315–325. [CrossRef] [PubMed]
49. Rutkunas, V.; Bukelskiene, V.; Sabaliauskas, V.; Balciunas, E.; Malinauskas, M.; Baltriukiene, D. Assessment
of human gingival fibroblast interaction with dental implant abutment materials. J. Mater. Sci. Mater. Med.
2015, 26, 169. [CrossRef] [PubMed]
50. Pae, A.; Lee, H.; Kim, H.-S.; Kwon, Y.-D.; Woo, Y.-H. Attachment and growth behaviour of human gingival
fibroblasts on titanium and zirconia ceramic surfaces. Biomed. Mater. 2009, 4, 25005. [CrossRef]
51. Raffaelli, L.; Iommetti, P.R.; Piccioni, E.; Toesca, A.; Serini, S.; Resci, F.; Missori, M.; De Spirito, M.;
Manicone, P.F.; Calviello, G. Growth, viability, adhesion potential, and fibronectin expression in fibroblasts
cultured on zirconia or feldspatic ceramics in vitro. J. Biomed. Mater. Res. Part A 2008, 86, 959–968. [CrossRef]
[PubMed]
52. International Standards Organization (ISO). Biological Evaluation of Medical Devices—Part 5: Tests for In Vitro
Cytotoxicity; 10993–5:2009; International Standards Organization: Geneva, Switzerland, 2009.
53. Elshahawy, W.M.; Watanabe, I.; Kramer, P. In vitro cytotoxicity evaluation of elemental ions released from
different prosthodontic materials. Dent. Mater. 2009, 25, 1551–1555. [CrossRef] [PubMed]
54. Roffel, S.; Wu, G.; Nedeljkovic, I.; Meyer, M.; Razafiarison, T.; Gibbs, S. Evaluation ofa novel oral mucosa
in vitro implantation model for analysis of molecularinteractions with dental abutment surfaces. Clin. Implant
Dent. Relat. Res. 2019, 21 (Suppl. 1), 25–33. [CrossRef] [PubMed]
55. Pabst, A.M.; Walter, C.; Bell, A.; Weyhrauch, M.; Schmidtmann, I.; Scheller, H.; Lehmann, K.M. Influence
of CAD/CAM zirconia for implant-abutment manufacturing on gingival fibroblasts and oral keratinocytes.
Clin. Oral Investig. 2016, 20, 1101–1108. [CrossRef] [PubMed]
56. Kwon, Y.-D.; Choi, H.-J.; Lee, H.; Lee, J.-W.; Weber, H.-P.; Pae, A. Cellular viability and genetic expression
of human gingival fibroblasts to zirconia with enamel matrix derivative (Emdogain®). J. Adv. Prosthodont.
2014, 6, 406–414. [CrossRef] [PubMed]
57. Knetsh, L.W.M. Chapter 13: Evolution of Current and Future Concepts of Biocompatibility Testing. In
Polymeric Biomaterials: Structure and Function, 1st ed.; Dumitriu, S., Popa, V., Eds.; CRC Press: Boca Raton, FL,
USA, 2013; Volume 1, pp. 385–396.
58. Sjögren, G.; Sletten, G.; Dahl, J.E. Cytotoxicity of dental alloys, metals, and ceramics assessed by Millipore
filter, agar overlay, and MTT tests. J. Prosthet. Dent. 2000, 84, 229–236. [CrossRef] [PubMed]
59. Wataha, J.; Craig, R.; Hanks, C. Precision of and new methods for testing in vitro alloy cytotoxicity. Dent. Mater.
1992, 8, 65–70. [CrossRef]
60. Imirzalioglu, P.; Alaaddinoglu, E.; Yilmaz, Z.; Oduncuoglu, B.; Yilmaz, B.; Rosenstiel, S. Influence of recasting
different types of dental alloys on gingival fibroblast cytotoxicity. J. Prosthet. Dent. 2012, 107, 24–33.
[CrossRef]
61. Nakonieczny, D.S.; Zie˛bowicz, A.; Paszenda, Z.K.; Krawczyk, C. Trends and perspectives in modification of
zirconium oxide for a dental prosthetic applications—A review. Biocybern. Biomed. Eng. 2017, 37, 229–245.
[CrossRef]
Polymers 2019, 11, 1446 15 of 15
62. Forster, A.; Ungvári, K.; Györgyey, Á.; Kukovecz, Á.; Turzó, K.; Nagy, K. Human epithelial tissue culture
study on restorative materials. J. Dent. 2014, 42, 7–14. [CrossRef]
63. Yamano, S.; Ma, A.K.-Y.; Shanti, R.M.; Kim, S.-W.; Wada, K.; Sukotjo, C. The influence of different implant
materials on human gingival fibroblast morphology, proliferation, and gene expression. Int. J. Oral Maxillofac.
Implants 2011, 26, 1247–1255.
64. Cho, Y.D.; Shin, J.C.; Yoon, H.I.; Ku, Y.; Ryoo, H.M.; Kim, D.J.; Kim, D.G.; Han, J.S. Characterization of
Human Gingival Fibroblasts on Zirconia Surfaces Containing Niobium Oxide. Materials 2015, 8, 6018–6028.
[CrossRef]
65. Elshahawy, W. Chapter 15: Biocompatibility. In Advances in Ceramics Electric and Magnetic Ceramics, Bioceramics,
Ceramics and Environment, 1st ed.; InTech Open: London, UK, 2011; pp. 359–374.
66. Milleding, P.; Karlsson, S.; Nyborg, L. On the surface elemental composition of non-corroded and corroded
dental ceramic materials in vitro. J. Mater. Sci. Mater. Med. 2003, 14, 557–566. [CrossRef] [PubMed]
67. Milleding, P.; Haraldsson, C.; Karlsson, S. Ion leaching from dental ceramics during static in vitro corrosion
testing. J. Biomed. Mater. Res. 2002, 61, 541–550. [CrossRef]
68. Sulaiman, T.A.; Abdulmajeed, A.A.; Shahramian, K.; Hupa, L.; Donovan, T.E.; Vallittu, P.; Närhi, T.O. Impact
of gastric acidic challenge on surface topography and optical properties of monolithic zirconia. Dent. Mater.
2015, 31, 1445–1452. [PubMed]
69. Seabra, A.B.; Durán, N. Nanotoxicology of Metal Oxide Nanoparticles. Metals 2015, 5, 934–975. [CrossRef]
70. Van Landuyt, K.; Nawrot, T.; Geebelen, B.; De Munck, J.; Snauwaert, J.; Yoshihara, K.; Scheers, H.; Godderis, L.;
Hoet, P.; Van Meerbeek, B. How much do resin-based dental materials release? A meta-analytical approach.
Dent. Mater. 2011, 27, 723–747. [CrossRef] [PubMed]
71. Ivkovic´, N.; Božovic´, D.; Ristic´, S.; Mirjanic´, V.; Jankovic´, O. The residual monomer in dental acrylic resin and
its adverse effects. Contemp. Mater. 2013, 1, 84–91. [CrossRef]
72. Brunot-Gohin, C.; Duval, J.-L.; Verbeke, S.; Belanger, K.; Pezron, I.; Kugel, G.; Laurent-Maquin, D.;
Gangloff, S.; Egles, C. Biocompatibility study of lithium disilicate and zirconium oxide ceramics for esthetic
dental abutments. J. Periodontal Implant. Sci. 2016, 46, 362–371. [CrossRef] [PubMed]
73. Sun, T.; Liu, R.; Liu, X.; Feng, X.; Zhang, Y.; Lai, R. The Biocompatibility of Dental Graded Nano-Glass-Zirconia
Material after Aging. Nanoscale Res. Lett. 2018, 13, 61. [CrossRef]
74. Kramer, P.R.; Janikkeith, A.; Cai, Z.; Ma, S.; Watanabe, I. Integrin mediated attachment of periodontal
ligament to titanium surfaces. Dent. Mater. 2009, 25, 877–883. [CrossRef]
75. Iyer, P.; Walker, K.J.; Madihally, S.V. Increased matrix synthesis by fibroblasts with decreased proliferation on
synthetic chitosan-gelatin porous structures. Biotechnol. Bioeng. 2012, 109, 1314–1325. [CrossRef]
76. Häkkinen, L.; Larjava, H.; Fournier, B.P. Distinct phenotype and therapeutic potential of gingival fibroblasts.
Cytotherapy 2014, 16, 1171–1186. [CrossRef] [PubMed]
77. Somerman, M.; Archer, S.; Imm, G.; Foster, R. A Comparative Study of Human Periodontal Ligament Cells
and Gingival Fibroblasts in vitro. J. Dent. Res. 1988, 67, 66–70. [CrossRef] [PubMed]
78. Palaiologou, A.A.; Yukna, R.A.; Moses, R.; Lallier, T.E. Gingival, dermal, and periodontal ligament fibroblasts
express different extracellular matrix receptors. J. Periodontol. 2001, 72, 798–807. [CrossRef] [PubMed]
79. Nor, N.H.M.; Berahim, Z.; Azlina, A.; Mokhtar, K.I.; Kannan, T.P. Identification and Characterization of
Intraoral and Dermal Fibroblasts Revisited. Curr. Stem Cell Res. Ther. 2017, 12, 675–681. [CrossRef]
80. Kournetas, N.; Spintzyk, S.; Schweizer, E.; Sawada, T.; Said, F.; Schmid, P.; Geis-Gerstorfer, J.; Eliades, G.;
Rupp, F. Comparative evaluation of topographical data of dental implant surfaces applying optical
interferometry and scanning electron microscopy. Dent. Mater. 2017, 33, e317–e327. [CrossRef] [PubMed]
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
